Anthrax, AIDS, Cancer, Baldness Cures...when will it soar? Well if any of us knew the future, we'd all be billionaires now instead of later. However, one can take an educated guess that Avanir ( www.avanir.com ) is poised to become the single most important investment of our lifetimes and $100+ is a conservative estimate of where it's heading short-term. Anyone who has followed this company knows for sure that every Wall Street shark try to put them out of business to take over the lucrative Xenerex patents they hold. These patents employ the same technology which Avanir used to perfect the anthrax mAB with near 100% positive results.
Now Avanir has a multi-billion dollar drug up for FDA priority approval with an 84% improvement rate in MS patients. The company has cleverly taken steps to stop any hostile takeover attemtps by the Wall Street sharks, thus allowing AVNR to move forward with their plans of raking in billions in profits from Neurodex and using those profits to fund the Xenerex project.
If Avanir can replicate their success in attacking defective genes in man with the same results that they have gotten with their anthrax mAB, they will well be on their way to becoming the single most important and cutting edge company in existence. We are talking about AIDs, cancer, baldness cures and cures to just about any other genetic defect in man using the information provided from genome mapping and employing Avanir's very unique and patented Xenerex antibody technology.
Yes, I'm betting it will soar (and that's an understatement). Even if I could forecast the future and knew exactly when it will soar, I wouldn't tell you. I'm loading up with as many shares as I can afford now while the foolish shorts have created an ideal situtation for longs to accumulate at ridiculously low prices. This is a move that they will regret for the rest of their lives. Don't forget to call your brokers today if you wish to buy shares today.
There is a new trading symbol for Avanir and you must contact your brokers.
Although Cramer did endorse this company but since then the stock price has decline about 50% within the last several weeks. This is largely due to the fact that this company has never made a profit since they started. They have reported 20 years of Negative Earnings.
Also, the NY Times did an expos� on this company and question their ethics. The author Andrew Pollack asked the question if it is ethical for a company to literally invent a disease just so they can market their drug? The disease is actually a condition brough on by life threatening diseases MS, ALS, etc... and all this drug does is mask the symptoms.